20240527_PYFA_Ringkasan Risalah//Risalah RUPS_31642605_lamp1.pdf

D.   The shareholders who attended the Meeting were listed in the Company's Shareholders’ Register
     as of the recording date of April 5, 2024 up to 16:00 Western Indonesia Time which was published
     by PT Sinartama Gunita as the Company's Securities Administration Bureau. The Meeting was
     attended by 313.111.340 (three hundred and thirteen million, one hundred eleven thousand,
     three hundred and forty) shares with valid voting rights or equivalent to 58,52% (fifty eight point
     fifty two percent) from the total of 535.080.000 (five hundred thirty five million and eighty
     thousand) shares with valid voting rights issued by the Company.

E. In the Meeting, each Shareholder/proxy was given the opportunity to seek inquiry and/or provide
   opinions, related to the Meeting agenda.

F. The decision-making mechanism in the Meeting is as follows:
   Meeting decisions were made by way of deliberation to reach consensus, if there were
   shareholders or their proxies who voted against or abstain, voting would then be done electronically
   through eASY.KSEI or physically (by way of show of hand for those against).

G. The number of shareholders or its proxy who sought inquiry and/or provided opinions as well as
   the results of the vote on the agenda of the Meeting is as follows :


                         The number of                               Voting Results
                      Shareholders/Proxies
         Meeting
                       who sought inquiry
         Agenda                                        Affirmative          Disapproval      Abstain
                        and/or provided
                           opinions
                                                   313.105.312 shares                          6,028
             1                   2                  (99,99% of those              0           shares
                                                        present)                             (0,001%)


H.   Whereas in the Company’s Meeting the following decisions have been made with unanimous
     votes:

     1. Approval on the Acquisition plan by the Company through PAPL on Probiotec Limited, which
        results in a change of control in Probiotec Limited by acquiring all shares owned by the
        shareholders of Probiotec Limited, which is considered a material transaction according to
        Article 6 paragraph 1 letter d number 1 of OJK Regulation 17/2020;
     2. Approval on the authorization of the Company's Board of Directors to take all necessary actions
        in connection with the Acquisition, in compliance with the applicable laws and regulations,
        including capital market regulations, including but is not limited to, drafting, signing, and
        submitting all documents and/or deeds, appearing before any relevant parties as needed, and
        providing information related to the aforementioned Meeting decision.


                                         Jakarta, 27 May 2024
                             The Board of Directors PT Pyridam Farma Tbk.